Cambridge, UK.
We’re pioneering Market Access innovations: this is the place to unlock opportunities and feed our love for the challenge. United by an unrivalled passion for patients and science and always performing at the top of our game.
Responsabilities:
- Collaborate with cross functional R&D, commercial, regional and country teams to develop, launch and commercialise AstraZeneca Oncology medicines.
- High quality health economics and payer evidence input into pharmaceutical development projects, payer evidence strategy and plans, and market access & pricing strategies.
- Matrix leads a cross functional team to support the development of payer strategy and evidence including payer statistical analyses, patient reported outcomes, health economics and real-world evidence.
- Delivery of health economics and payer evidence related activities, and give to work streams, to ensure optimal access of our life changing medicines to patients.
- Deliver clear, customer-focused and robust Global Reimbursement Dossiers (GRDs).
- Ensure target product profiles and target claims can meet payer needs and necessary supporting evidence is developed.
- Apply your knowledge to support decision-making processes, value demonstration and commercialization of products including through Health Technology Assessment (HTA).
- Advocate and champion the need for scientifically sound trial and non-trial data (including RWE, economic modelling, meta-analyses, observational studies, and PRO approaches).
- Collaborate with marketing companies/local affiliates in preparing evidence that satisfies their local payer requirements.
- Contribute to peer reviewed scientific publications, as well as effective communication of complex ideas for use with both payers and other partners.
- Participate in external health economics and payer evidence departmental activities via technical presentations, committee membership, publication reviews, and other similar activities.
- Interact with HTA authorities and advisors/key external guides in preparing materials for scientific advice or reimbursement submissions.
The HEPE Director will lead the global health economic and payer evidence strategy and plan, working closely across two key tumours; breast cancer and prostate cancer. In particular, after recent successful readouts in adjuvant breast cancer (OLYMPIA) and prostate cancer (PROpel) they will be pivotal in shaping and preparing for launch across our key countries. The successful candidate will work closely with the pricing and market access director, the DDR simulation and modelling team, our marketing companies (local affiliates), our alliance partner, and cross functionally, with an expectation that they will make impact into strategic discussions across R&D, medical and commercial.
Essential Requirements
- Graduate degree or equivalent experience in biomedical science, business, quantitative subject areas or economics.
- Oncology therapy area experience
- Local or global launch experience, having worked at a senior level within a health economic consultancy or several years in a pharmaceutical company (either at a marketing company/local affiliate or global level).
- Ability to communicate technical matters in a clear, compelling and impactful way with others via a range of media (e.g. face to face, teleconferences, video conferences, formal presentations, strong scientific writing for reports, analysis plans and emails).
Desirable Requirements
- Global payer launch experience and global payer evidence development experience.
- Post-graduate degree in health economics or a related quantitative subject area
This job ad will be unpublished on 13/12/2024.
This job is posted by AstraZeneca.
This link brings you to the website of AstraZeneca.
Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!
